# FDA Inspection 1107254 - Alnylam Pharmaceuticals, Inc. - September 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/alnylam-pharmaceuticals-inc/153835da-dbb4-4e37-902e-42fb538b42fa
Source feed: FDA_Inspections

> FDA Inspection 1107254 for Alnylam Pharmaceuticals, Inc. on September 18, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1107254
- Company Name: Alnylam Pharmaceuticals, Inc.
- Inspection Date: 2019-09-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1181120 - 2022-09-09](https://www.keypedia.com/records/fda_inspections/alnylam-pharmaceuticals-inc/2012957c-a4fe-4050-9fda-eda32264fa9b)
- [FDA Inspection 1050979 - 2018-04-25](https://www.keypedia.com/records/fda_inspections/alnylam-pharmaceuticals-inc/416acd03-3f7b-46f1-a91a-64c29ee36158)

Company: https://www.keypedia.com/companies/alnylam-pharmaceuticals-inc/918c30c3-22a5-436f-88c1-6af91b2c575a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c